Soliani Luca, Alcalá San Martín Adrián, Balsells Sol, Hernando-Davalillo Cristina, Ortigoza-Escobar Juan Darío
IRCCS Istituto delle Scienze Neurologiche di Bologna UOC Neuropsichiatria dell'età Pediatrica Bologna Italy.
Dipartimento di Scienze Mediche e Chirurgiche (DIMEC) Università di Bologna Bologna Italy.
Mov Disord Clin Pract. 2023 Mar 16;10(4):547-557. doi: 10.1002/mdc3.13711. eCollection 2023 Apr.
Chromosome microarray analysis (CMA) can detect copy number variants (CNV) beyond the resolution of standard G-banded karyotyping. De novo or inherited microdeletions may cause autosomal dominant movement disorders.
The purpose of this study was to analyze the clinical characteristics, associated features, and genetic information of children with deletions in known genes that cause movement disorders and to make recommendations regarding the diagnostic application of CMA.
Clinical cases published in English were identified in scientific databases (PubMed, ClinVar, and DECIPHER) from January 1998 to July 2019 following Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines. Cases with deletions or microdeletions greater than 300 kb were selected. Information collected included age, sex, movement disorders, associated features, and the size and location of the deletion. Duplications or microduplications were not included.
A total of 18.097 records were reviewed, and 171 individuals were identified. Ataxia (30.4%), stereotypies (23.9%), and dystonia (21%) were the most common movement disorders. A total of 16% of the patients demonstrated more than one movement disorder. The most common associated features were intellectual disability or developmental delay (78.9%) and facial dysmorphism (57.8%). The majority (77.7%) of microdeletions were smaller than 5 Mb. We find no correlation between movement disorders, their associated features, and the size of microdeletions.
Our results support the use of CMA as an investigational test in children with movement disorders. As the majority of identified articles were case reports and small case series (low quality), future efforts should focus on larger prospective studies to examine the causation of microdeletions in pediatric movement disorders.
染色体微阵列分析(CMA)能够检测超出标准G带核型分辨率的拷贝数变异(CNV)。新发或遗传的微缺失可能导致常染色体显性运动障碍。
本研究旨在分析已知导致运动障碍的基因发生缺失的儿童的临床特征、相关特征和遗传信息,并就CMA的诊断应用提出建议。
按照系统评价和Meta分析的首选报告项目指南,在科学数据库(PubMed、ClinVar和DECIPHER)中检索1998年1月至2019年7月以英文发表的临床病例。选择缺失或微缺失大于300 kb的病例。收集的信息包括年龄、性别、运动障碍、相关特征以及缺失的大小和位置。不包括重复或微重复。
共检索18097条记录,确定171例个体。共济失调(30.4%)、刻板动作(23.9%)和肌张力障碍(21%)是最常见的运动障碍。共有16%的患者表现出一种以上的运动障碍。最常见的相关特征是智力残疾或发育迟缓(78.9%)和面部畸形(57.8%)。大多数(77.7%)微缺失小于5 Mb。我们发现运动障碍、其相关特征与微缺失大小之间无相关性。
我们的结果支持将CMA用作运动障碍儿童的一项研究性检测。由于大多数已识别的文章为病例报告和小病例系列(质量低),未来的工作应侧重于更大规模的前瞻性研究,以探讨儿童运动障碍中微缺失的病因。